Pancreatic Neoplasms
📧 Sign up to get email alerts when something new happens for Pancreatic Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-19Clinical Trial Update: Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of Esperanza Extract (PA001) for various neoplastic conditions; current status i…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer [Phase 1, Phase 2]
Phase 1/2 trial of M7824 (immune checkpoint inhibitor) and M9241 (immunocytokine) with SBRT in adults with advanced pancreatic cancer; study…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer [Phase 2]
Phase II trial evaluating BI 2536, a PLK-1 inhibitor, in advanced, unresectable pancreatic cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy [Phase 2]
Phase 2 trial update evaluating neoprene-based glue for treating the pancreatic stump after high-risk pancreatoduodenectomy.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer [Phase 1, Phase 2]
A safety study of 90Y-hMN14 for pancreatic cancer across Phase 1 and Phase 2 has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating VEGFR/PDGFR dual kinase inhibitor X-82 in combination with Everolimus for pancreatic neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Combination With Gemcitabine in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 trial updating combination therapy with gemcitabine in advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy [Phase 4]
A Phase 4 trial comparing EUS-Coeliac Plexus Block to radiofrequency ablation for pain relief in patients with pancreatic cancer/pancreatic …
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant nab-paclitaxel and S-1 in resectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating LMB-100 alone or with nab-paclitaxel in previously treated metastatic and/or locally advanced pancreatic ductal a…
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial update evaluating fluorouracil and oxaliplatin as first-line therapy for advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: Trial of Curcumin in Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating curcumin in advanced pancreatic cancer has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications [Phase 4]
Phase 4 trial comparing hydrocortisone to pasireotide in reducing pancreatic surgery complications.
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours [Phase 2]
Phase 2 trial assessing safety and efficacy of TH-302 in combination with sunitinib for neuroendocrine pancreatic tumors has completed with …
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Tremelimumab and/or MEDI4736 (durvalumab) in combination with radiation therapy for unresectable pancr…
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating NC-6004 in combination with gemcitabine versus gemcitabine alone in pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Trial Comparing 19 and 25-gauge EUS-FNA Needles [NA]
Completed clinical trial comparing 19- and 25-gauge EUS-FNA needles; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) [Phase 3]
Phase 3 trial comparing nab-paclitaxel plus gemcitabine vs gemcitabine alone as adjuvant therapy for resected pancreatic cancer; completed w…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: CTC Pancreatic Adenocarcinoma [Phase 4]
Phase 4 clinical trial update for circulating tumor cell (CTC) considerations in pancreatic adenocarcinoma; study completed.
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dendritic cell immunotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-20Clinical Trial Update: Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery [Phase 2]
Phase 2 clinical trial investigating perioperative intervention to reduce metastatic processes in pancreatic cancer patients undergoing cura…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Acelarin First Line Randomised Pancreatic Study [Phase 2, Phase 3]
A randomized study of Acelarin in first-line pancreatic cancer is currently suspended, with both Phase 2 and Phase 3 components reported.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient [Phase 1, Phase 2]
Clinical trial update reporting safety and efficacy of Mix Vaccine in pancreatic carcinoma, completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for PEP02 as second-line therapy in metastatic pancreatic cancer has completed recruitment and status is compl…
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Gemcitabine and CT-011 for Resected Pancreatic Cancer [Phase 2]
Phase 2 trial update for gemcitabine with CT-011 in resected pancreatic cancer was terminated; results posted in 2019.